Gambia: PS Ceesay Says Malaria Control Requires Joint Partnership
[Daily Observer] Dawda Ceesay, the permanent secretary at the Ministry of Health and Social Welfare has stated that Malaria control requires joint partnership, as the task for Malaria control is colossal but it has to be tackled head on by the Gambian population.
[The Conversation Africa] The 2017 World Malaria Report provides a clear picture of the work required to control malaria. Data from over 90 countries reveals a dramatic reduction in the rates of disease and deaths between 2010 to 2015. But malaria deaths remained unchanged in Africa from 2015 to 2016.
[African Union] The African Union and the Global Fund to Fight AIDS, TB and Malaria on Wednesday jointly organised a satellite symposium on domestic health financing. Despite significant progress in responding to the AIDS epidemic Africa confronts the world's most acute public health threats that remain largely underfunded. After decades of underinvestment the continent need sustained investments in health in a context where international support has levelled due to many competing global priorities.
[AIM] The National Malaria Control Programme (PNCM) in the Ministry of Health plans to reduce the prevalence of malaria in the country from the current figure of 40 per cent to 24 per cent by 2022.
[AIM] President Filipe Nyusi on 8 December urged the Ministry of Health to lead a massive campaign against malaria in 2018. Speaking at the ceremony to lay the first stone for a new general hospital in the northern city of Nampula, President Nyusi expressed his concern at the large number of cases of malaria in Nampula province.
Abstract Antimalarial drug resistance has emerged as a threat for treating malaria, generating a need to design and develop newer, more efficient antimalarial agents. This research aimed to identify novel leads as antimalarials. Dual receptor mechanism could be a good strategy to combat developing drug resistance. A series of benzimidazole acrylonitriles containing 18 compounds were designed, synthesized and evaluated for cytotoxicity, heme binding, ferriprotoporphyrin IX biomineralisation inhibition, and falcipain‐2 enzyme assay. Furthermore, in silico docking and MD simulation studies were also performed.The tests reve...
ConclusionIn order to respond effectively to uncertain future scenarios for vector-borne disease in a changing world, more attention needs to be given to building resilient and equitable systems in the present.
We evaluated existing data on the prophylactic efficacy of atovaquone-proguanil (AP) in order to determine whether prophylaxis in travellers can be discontinued on the day of return from a malaria-endemic area instead of seven days after return as per currently recommended post-travel schedule.